LGRCX vs. NEFRX
Compare and contrast key facts about Loomis Sayles Growth Fund Class C (LGRCX) and Loomis Sayles Core Plus Bond Fund (NEFRX).
LGRCX is managed by Natixis. It was launched on Feb 1, 2013. NEFRX is managed by Natixis. It was launched on Nov 7, 1973.
Performance
LGRCX vs. NEFRX - Performance Comparison
Loading graphics...
LGRCX vs. NEFRX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
LGRCX Loomis Sayles Growth Fund Class C | -11.85% | 12.90% | 33.77% | 49.68% | -28.62% | 17.50% | 30.41% | 30.47% | -3.53% | 31.39% |
NEFRX Loomis Sayles Core Plus Bond Fund | -0.38% | 7.24% | 0.60% | 5.91% | -12.94% | -1.68% | 10.29% | 8.76% | -0.86% | 4.92% |
Returns By Period
In the year-to-date period, LGRCX achieves a -11.85% return, which is significantly lower than NEFRX's -0.38% return. Over the past 10 years, LGRCX has outperformed NEFRX with an annualized return of 14.27%, while NEFRX has yielded a comparatively lower 2.28% annualized return.
LGRCX
- 1D
- 3.76%
- 1M
- -6.13%
- YTD
- -11.85%
- 6M
- -12.50%
- 1Y
- 10.22%
- 3Y*
- 18.06%
- 5Y*
- 9.91%
- 10Y*
- 14.27%
NEFRX
- 1D
- 0.26%
- 1M
- -1.88%
- YTD
- -0.38%
- 6M
- 0.27%
- 1Y
- 3.58%
- 3Y*
- 3.15%
- 5Y*
- 0.05%
- 10Y*
- 2.28%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LGRCX vs. NEFRX - Expense Ratio Comparison
LGRCX has a 1.65% expense ratio, which is higher than NEFRX's 0.71% expense ratio.
Return for Risk
LGRCX vs. NEFRX — Risk / Return Rank
LGRCX
NEFRX
LGRCX vs. NEFRX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Loomis Sayles Growth Fund Class C (LGRCX) and Loomis Sayles Core Plus Bond Fund (NEFRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LGRCX | NEFRX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.53 | 0.98 | -0.44 |
Sortino ratioReturn per unit of downside risk | 0.98 | 1.42 | -0.44 |
Omega ratioGain probability vs. loss probability | 1.13 | 1.18 | -0.05 |
Calmar ratioReturn relative to maximum drawdown | -0.18 | 2.22 | -2.40 |
Martin ratioReturn relative to average drawdown | -0.53 | 7.31 | -7.83 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| LGRCX | NEFRX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.53 | 0.98 | -0.44 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.45 | 0.01 | +0.44 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.69 | 0.46 | +0.23 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.48 | 0.73 | -0.25 |
Correlation
The correlation between LGRCX and NEFRX is -0.02. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.
Dividends
LGRCX vs. NEFRX - Dividend Comparison
LGRCX's dividend yield for the trailing twelve months is around 3.51%, less than NEFRX's 3.63% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LGRCX Loomis Sayles Growth Fund Class C | 3.51% | 3.10% | 7.70% | 8.01% | 21.28% | 5.81% | 5.14% | 2.60% | 6.05% | 2.18% | 1.36% | 0.00% |
NEFRX Loomis Sayles Core Plus Bond Fund | 3.63% | 3.97% | 3.90% | 3.58% | 3.10% | 2.34% | 4.04% | 2.51% | 2.87% | 2.68% | 3.17% | 2.58% |
Drawdowns
LGRCX vs. NEFRX - Drawdown Comparison
The maximum LGRCX drawdown since its inception was -58.53%, which is greater than NEFRX's maximum drawdown of -25.45%. Use the drawdown chart below to compare losses from any high point for LGRCX and NEFRX.
Loading graphics...
Drawdown Indicators
| LGRCX | NEFRX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.53% | -25.45% | -33.08% |
Max Drawdown (1Y)Largest decline over 1 year | -18.16% | -3.12% | -15.04% |
Max Drawdown (5Y)Largest decline over 5 years | -35.31% | -18.55% | -16.76% |
Max Drawdown (10Y)Largest decline over 10 years | -35.31% | -18.76% | -16.55% |
Current DrawdownCurrent decline from peak | -14.91% | -2.57% | -12.34% |
Average DrawdownAverage peak-to-trough decline | -11.13% | -3.97% | -7.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.05% | 0.95% | +7.10% |
Volatility
LGRCX vs. NEFRX - Volatility Comparison
Loomis Sayles Growth Fund Class C (LGRCX) has a higher volatility of 6.48% compared to Loomis Sayles Core Plus Bond Fund (NEFRX) at 1.52%. This indicates that LGRCX's price experiences larger fluctuations and is considered to be riskier than NEFRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| LGRCX | NEFRX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.48% | 1.52% | +4.96% |
Volatility (6M)Calculated over the trailing 6-month period | 12.97% | 2.85% | +10.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 25.32% | 4.99% | +20.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.06% | 6.20% | +16.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 21.10% | 5.02% | +16.08% |